Becton, Dickinson and Company (LON: 0R19)
London
· Delayed Price · Currency is GBP · Price in USD| Market Cap | 52.36B |
| Revenue (ttm) | 15.05B |
| Net Income (ttm) | 1.27B |
| Shares Out | n/a |
| EPS (ttm) | 4.37 |
| PE Ratio | 41.16 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Dec 9, 2024 |
| Volume | 655 |
| Open | 223.96 |
| Previous Close | 224.12 |
| Day's Range | 223.50 - 228.50 |
| 52-Week Range | 223.50 - 286.33 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 6, 2025 |
About Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system... [Read more]
Financial Performance
In 2024, Becton, Dickinson and Company's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.
Financial numbers in USD Financial StatementsNews
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
FRANKLIN LAKES, N.J. and AUSTIN, Texas , Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-fi...
Becton, Dickinson to pay $175M to settle claims over misleading investors
Becton Dickinson to Pay $175 Million to Settle SEC Probe
Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled investors about one of its most important products.
Becton Dickinson settles charges over infusion pump risks, SEC says
The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. over allegations it misled investors about risks associated with its Alaris infusio...
Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump
Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device...
BD Resolves Previously Disclosed SEC Investigation
FRANKLIN LAKES, N.J. , Dec. 16, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement: BD has reached a...
(BDX) - Analyzing Becton Dickinson's Short Interest
Becton Dickinson's (NYSE: BDX) short percent of float has fallen 9.59% since its last report. The company recently reported that it has 1.90 million shares sold short , which is 0.66% of all regular ...
Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance He...
12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style
The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Divid...
These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More
With a new presidential administration set to take office on Jan. 20, 2025, some investors may be uncertain about how new policies and personnel will affect the stock market and interest rates. Will t...
11 Compounder opportunities according to Goldman: AMD, BDX, INFA
Goldman Sachs analysts highlighted 11 buy-rated companies that offer a combination of quality characteristics.
17 Upcoming Dividend Increases, Including A King
With the holiday season underway, I present 17 companies with dividend increases for 2024, including Becton, Dickinson, and Company, a dividend king with a 52-year streak. My strategy focuses on buyin...
Becton, Dickinson and Company (BDX) 7th Annual Evercore ISI HealthCONx Conference (Transcript)
VPL Welcomes Mark Longley as Chief Executive Officer; Eric McGlade, CEO and Co-Founder, Named Chairman of the Board
WESTERVILLE, Ohio--(BUSINESS WIRE)-- #HealthcareLogistics--Vantage Point Logistics ("VPL") announced today that Mark Longley will join the company as its Chief Executive Officer.
Beyond the Balance Sheet: What SWOT Reveals About Becton Dickinson & Co (BDX)
Beyond the Balance Sheet: What SWOT Reveals About Becton Dickinson & Co (BDX)
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
On Tuesday, Embecta Corp (NASDAQ: EMBC) posted the fourth-quarter adjusted EPS of 45 cents, beating the consensus of 36 cents and down from 59 cents reported a year ago. The company reported quarterl...
My Best Dividend Aristocrats For December 2024
The ProShares S&P 500 Dividend Aristocrat ETF is up 10.26% year-to-date through October. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 40 mon...
First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities
BROWNSVILLE, Texas , Nov. 20, 2024 /PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in underserved co...
BD to Present at the 7th Annual Evercore ISI HealthCONx Conference
FRANKLIN LAKES, N.J. , Nov. 19, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7th Annual...
Becton, Dickinson and Company Q4: Shifting To High-Growth Areas
Becton, Dickinson and Company is projected to achieve 8.8%-9.3% revenue growth in FY25, driven by new product launches and the APM business. The acquisition of Edwards Lifesciences' Critical Care prod...
Becton, Dickinson and Company (BDX) Q4 2024 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX) Q4 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer & Head of Investor Relations...
Becton Dickinson beats quarterly estimates on strength in drug-delivery devices
Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices.
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
Strong Growth and Margin Execution Drives Performance in Quarter Q4 revenue of $5.4 billion increased 6.9% as reported, 7.4% currency-neutral and 6.2% organic Q4 GAAP and adjusted diluted EPS from con...
BD Board Increases Dividend for 53rd Consecutive Year
FRANKLIN LAKES, N.J. , Nov. 7, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, an increase of...
Becton, Dickinson And HP Among 13 Companies To Announce Annual Dividend Increases In First Half Of November
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. I expect 13 companies to announce their annual increases i...